The effect of gonadotropin-releasing hormone agonist on embryo quality and pregnancy rate following cryopreservation**Presented at the Annual Meeting of The Israeli Society of Fertility, Tel Aviv, Israel, March 3 to 4, 1992.

Abraham Benshushan; Yossef Ezra; Alex Simon; Nathan Mordel; Aby Lewin; Neri Laufer

doi:10.1016/s0015-0282(16)55929-9

The effect of gonadotropin-releasing hormone agonist on embryo quality and pregnancy rate following cryopreservation**Presented at the Annual Meeting of The Israeli Society of Fertility, Tel Aviv, Israel, March 3 to 4, 1992.

Fertility and Sterility ◽

10.1016/s0015-0282(16)55929-9 ◽

1993 ◽

Vol 59 (5) ◽

pp. 1065-1069 ◽

Cited By ~ 4

Author(s):

Abraham Benshushan ◽

Yossef Ezra ◽

Alex Simon ◽

Nathan Mordel ◽

Aby Lewin ◽

...

Keyword(s):

Pregnancy Rate ◽

Annual Meeting ◽

Embryo Quality ◽

Gonadotropin Releasing Hormone ◽

Israeli Society ◽

Releasing Hormone ◽

Tel Aviv ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression**Presented at the Forty-Fifth Annual Meeting of The American Fertility Society, November 11 to 16, 1989, San Francisco, California.

Fertility and Sterility ◽

10.1016/s0015-0282(16)53224-5 ◽

1990 ◽

Vol 53 (1) ◽

pp. 103-106 ◽

Cited By ~ 32

Author(s):

Michael C. Edelstein ◽

Robert G. Brzyski ◽

Georgeanna S. Jones ◽

Simonetta Simonetti ◽

Suheil J. Muasher

Keyword(s):

Annual Meeting ◽

San Francisco ◽

Follicle Stimulating Hormone ◽

Gonadotropin Releasing Hormone ◽

Human Menopausal Gonadotropin ◽

Releasing Hormone ◽

Hormone Stimulation ◽

Gonadotropin Releasing Hormone Agonist ◽

American Fertility Society ◽

Stimulating Hormone

Download Full-text

Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy**Presented in part at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, Ontario, Canada, March 31 to April 3, 1993.††Funded by a grant from TAP Pharmaceuticals, Deerfield, Illinois.

Fertility and Sterility ◽

10.1016/s0015-0282(16)57476-7 ◽

1995 ◽

Vol 63 (4) ◽

pp. 747-755 ◽

Cited By ~ 40

Author(s):

Eric S. Surrey ◽

Barbara Voigt ◽

Nicole Fournet ◽

Howard L. Judd

Keyword(s):

Annual Meeting ◽

Low Dose ◽

Gonadotropin Releasing Hormone ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

Faculty Opinions recommendation of Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735175407.793557189 ◽

2019 ◽

Author(s):

Felice Petraglia ◽

Silvia Vannuccini

Keyword(s):

Pregnancy Rate ◽

Embryo Transfer ◽

Gonadotropin Releasing Hormone ◽

Frozen Embryo Transfer ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction**Presented at the 35th Annual Meeting of the Society for Gynecologic Investigation, Baltimore, Maryland, March 17 to 20, 1988.

Fertility and Sterility ◽

10.1016/s0015-0282(16)54890-0 ◽

1992 ◽

Vol 57 (3) ◽

pp. 495-500 ◽

Cited By ~ 27

Author(s):

Marcelle I. Cedars ◽

Kenneth A. Steingold ◽

Dominique de Ziegler ◽

Philip S. Lapolt ◽

R. Jeffrey Chang ◽

...

Keyword(s):

Annual Meeting ◽

Gonadotropin Releasing Hormone ◽

Ovarian Dysfunction ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Term Administration

Download Full-text

Contrasting effects of a gonadotropin-releasing hormone agonist and antagonist on the secretion of free α subunit**Supported in part by National Institute of Health contract 1-HD-4-2801, Bethesda, Maryland.††Presented in part at the 71st Annual Meeting of the Endocrine Society, Seattle, Washington, June 21 to 24, 1989.

Fertility and Sterility ◽

10.1016/s0015-0282(16)56600-x ◽

1994 ◽

Vol 61 (3) ◽

pp. 573-575 ◽

Cited By ~ 6

Author(s):

Margo R. Fluker ◽

Scott E. Monroe ◽

Lorna A. Marshall ◽

Robert B. Jaffe

Keyword(s):

Annual Meeting ◽

Gonadotropin Releasing Hormone ◽

Endocrine Society ◽

Α Subunit ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist ◽

Agonist And Antagonist

Download Full-text

An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol

Fertility and Sterility ◽

10.1016/j.fertnstert.2008.06.036 ◽

2009 ◽

Vol 92 (2) ◽

pp. 508-514 ◽

Cited By ~ 28

Author(s):

Tsung-Hsuan Lai ◽

Fa-Kung Lee ◽

Tseng-Kai Lin ◽

Shang-Gwo Horng ◽

Su-Chee Chen ◽

...

Keyword(s):

Pregnancy Rate ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Ovarian Reserve ◽

Negative Impact ◽

Gonadotropin Releasing Hormone ◽

Clinical Pregnancy ◽

Serum Progesterone ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate**Awarded the Organon Prize for the best paper by a trainee at the 12th Annual Meeting of the Fertility Society of Australia, Sydney, November 3 to 6, 1993.

Fertility and Sterility ◽

10.1016/s0015-0282(16)57443-3 ◽

1995 ◽

Vol 63 (3) ◽

pp. 663-665 ◽

Cited By ~ 18

Author(s):

Umit Sungurtekin ◽

Robert P.S. Jansen

Keyword(s):

Luteinizing Hormone ◽

Annual Meeting ◽

Gonadotropin Releasing Hormone ◽

Leuprolide Acetate ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

Prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the clinical pregnancy rate in intrauterine insemination treatment

Fertility and Sterility ◽

10.1016/j.fertnstert.2014.07.1030 ◽

2014 ◽

Vol 102 (3) ◽

pp. e303

Author(s):

S.-Y. Shen ◽

P.-C. Ma ◽

M.-I. Hsu ◽

C.-R. Tzeng

Keyword(s):

Pregnancy Rate ◽

Intrauterine Insemination ◽

Gonadotropin Releasing Hormone ◽

Clinical Pregnancy ◽

Clinical Pregnancy Rate ◽

Down Regulation ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

Relationship between follicular fluid hormone levels, embryo quality, and maternal age duringin vitrofertilization after the short or long protocol with a gonadotropin releasing hormone agonist

Reproductive Medicine and Biology ◽

10.1111/j.1447-0578.2003.00042.x ◽

2003 ◽

Vol 2 (4) ◽

pp. 165-169 ◽

Cited By ~ 4

Author(s):

Yoshimasa Yokota ◽

Mikako Yokota ◽

Hidemi Yokota ◽

Yasuko Ishikawa ◽

Setsuko Sato ◽

...

Keyword(s):

Follicular Fluid ◽

Maternal Age ◽

Embryo Quality ◽

Gonadotropin Releasing Hormone ◽

Releasing Hormone ◽

Hormone Levels ◽

Gonadotropin Releasing Hormone Agonist ◽

Long Protocol

Download Full-text

Pregnancy Rate and Preservation of Cyclic Ovarian Function With Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy—Reply

JAMA Oncology ◽

10.1001/jamaoncol.2015.5743 ◽

2016 ◽

Vol 2 (4) ◽

pp. 546 ◽

Cited By ~ 1

Author(s):

Isabelle Demeestere ◽

Volkan Turan ◽

Kutluk Oktay

Keyword(s):

Pregnancy Rate ◽

Ovarian Function ◽

Gonadotropin Releasing Hormone ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text